Clinical Trial Update: Combination Study With MVA BN and Dryvax [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating a combination of MVA-BN and Dryvax vaccines for smallpox has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Smallpox

Drugs mentioned

• Dryvax (Vaccinia virus vaccine)
• MVA-BN (Modified vaccinia Ankara Bavarian Nordic)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Smallpox | Phase 1 | Status: COMPLETED